Retour
Prix NovaBay Pharmaceuticals Inc (NBY)
Graphique du cours de l'action NBY
NBY Prévision du cours des actions
NovaBay Pharmaceuticals Inc
$0.58
-12.23%
$-0.08
À la fermeture : Feb 12, 16:00:00 GMT-5
$0.59
1.54%
$0
Pré-Marché: Feb 13, 06:00:22 GMT-5
Statistiques clés
Clôture préc.
$0.662
Prix d'ouverture
$0.6708
Plage de la journée
$0.5806 - $0.7199
Plage de 52 semaines
$0.46 - $19.95
Volume
991.4K
Volume moyen
1.8M
BPA (TTM)
-6.62
Rendement en dividend
--
Capitalisation boursière
$74.3M
Qu’est-ce que NBY ?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.